JP2024529185A5 - - Google Patents

Info

Publication number
JP2024529185A5
JP2024529185A5 JP2024532367A JP2024532367A JP2024529185A5 JP 2024529185 A5 JP2024529185 A5 JP 2024529185A5 JP 2024532367 A JP2024532367 A JP 2024532367A JP 2024532367 A JP2024532367 A JP 2024532367A JP 2024529185 A5 JP2024529185 A5 JP 2024529185A5
Authority
JP
Japan
Prior art keywords
composition
pharmaceutically acceptable
total weight
weight
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024532367A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024529185A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/039543 external-priority patent/WO2023014956A1/en
Publication of JP2024529185A publication Critical patent/JP2024529185A/ja
Publication of JP2024529185A5 publication Critical patent/JP2024529185A5/ja
Pending legal-status Critical Current

Links

JP2024532367A 2021-08-06 2022-08-05 ラジプロジルの製剤化 Pending JP2024529185A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163230331P 2021-08-06 2021-08-06
US63/230,331 2021-08-06
PCT/US2022/039543 WO2023014956A1 (en) 2021-08-06 2022-08-05 Formulations of radiprodil

Publications (2)

Publication Number Publication Date
JP2024529185A JP2024529185A (ja) 2024-08-01
JP2024529185A5 true JP2024529185A5 (https=) 2025-08-14

Family

ID=83189017

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024532367A Pending JP2024529185A (ja) 2021-08-06 2022-08-05 ラジプロジルの製剤化

Country Status (12)

Country Link
US (2) US20250127770A1 (https=)
EP (1) EP4380547A1 (https=)
JP (1) JP2024529185A (https=)
KR (1) KR20240052765A (https=)
CN (1) CN118019521A (https=)
AU (1) AU2022323381A1 (https=)
CA (1) CA3228004A1 (https=)
CO (1) CO2024002715A2 (https=)
IL (1) IL310652A (https=)
MX (1) MX2024001744A (https=)
PE (1) PE20241385A1 (https=)
WO (1) WO2023014956A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025137652A2 (en) * 2023-12-20 2025-06-26 Grin Therapeutics, Inc. Methods of using radiprodil in the treatment of disorders

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2453383C (en) 2001-07-24 2010-04-06 Richter Gedeon Vegyeszeti Gyar Rt Piperidine derivatives as nmda receptor antagonists
CA2730253A1 (en) * 2008-07-08 2010-01-14 Alphonso Higuera Novel crystalline form of 2-[4-(4-fluoro-benzyl)-piperidine-1-yl]-2-oxo-n-(2-oxo-2,3-dihydro-benzoxazol-6-yl)-acetamide
AU2009282822A1 (en) * 2008-08-21 2010-02-25 Richter Gedeon Nyrt. Methods for treating CNS disorders
HUP0900130A3 (en) * 2009-03-03 2012-02-28 Richter Gedeon Nyrt Novel crystalline hydrate, amorphous and polymorphic forms of dihydro-benzoxazole-6-yl-acetamide derivative and processes for their preparation
US8328687B2 (en) 2010-07-09 2012-12-11 Ford Global Technologies, Llc Method for controlling an engine that may be automatically stopped

Similar Documents

Publication Publication Date Title
EP2760821B1 (en) Choline salt of an anti-inflammatory substituted cyclobutenedione compound
JP2005518405A5 (https=)
JP2022511029A5 (https=)
JP2018503611A5 (https=)
JP2025506374A5 (https=)
ES2197087T3 (es) Tabletas tragables con alto contenido de n-acetilcisteina.
JPS6241646B2 (https=)
JP2024529185A5 (https=)
JP2024045113A5 (https=)
AU2005204014B2 (en) Pharmaceutical compositions comprising a proton pump inhibitor and a prokinetic agent
JP2013533881A (ja) バノキセリンを含有する医薬組成物
WO2005082330A2 (en) Co-precipitated amorphous cefditoren pivoxil and dosage forms comprising the same
WO2001019350A1 (en) Controlled release formulation for administration of an anti-inflammatory naphthalene derivative
EP2709596A1 (en) Effervescent formulations comprising dexketoprofen
WO2013151518A1 (en) Capsule formulations comprising ceftibuten
WO1996030016A2 (en) Low dose ridogrel formulations and their use for the treatment of inflammatory bowel diseases
WO2011141419A1 (en) Association of the xanthine oxidase inhibitor febuxostat and metformin and use thereof
JP2012072061A (ja) 新規組成物
CA2286904A1 (en) Pharmaceutical tablet of amiodarone salt
WO2013077829A1 (en) Water-soluble pharmaceutical granules
JP6965497B2 (ja) レボセチリジン固形製剤
US20070299054A1 (en) Oral pharmaceutical composition of a poorly water-soluble active agent
WO2013100879A1 (en) Pharmaceutical compositions comprising quetiapine
RU2811593C1 (ru) Фармацевтическая композиция, включающая эзомепразол (варианты), пероральная лекарственная форма на основе фармацевтической композиции, включающей эзомепразол, способ получения и применение пероральной лекарственной формы на основе фармацевтической композиции, включающей эзомепразол
WO2012039691A2 (en) Synergic effect